Albumedix

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

A quick fix for Albumedix

Nottingham-based pharmaceutical manufacturer, Albumedix, has long been a leader in the field of recombinant albumin-based solutions. However, when a power cut-induced water leak threatened to derail operations, swift action was required to ensure that this problem did not escalate into a full-blown crisis. Fortunately, one of Alfa Laval’s field service engineers was at hand to get things back up and running
Ingredients

Sartorius makes $500m acquisition of biopharma component manufacturer

The life science group's French subgroup Sartorius Stedim Biotech has agreed to acquired UK-based Albumedix to be part of the Bioprocess Solutions Division
Manufacturing

Albumedix expands capacity at albumin manufacturing plant

The expanded manufacturing facility will allow Albumedix to meet demand from a growing portfolio of clients
Finance

Albumedix enters distribution agreement with Fujifilm Wako

The companies will work together to supply recombinant human albumin for the Japanese, Chinese and Hong Kong markets
Finance

Albumedix enters agreement with CGT catapult

Activities under this agreement will be carried out both at the CGT Catapult facility in Braintree and at Albumedix’s R&D centre
Regulatory

Albumedix establishes new regulatory department following DMF acceptance

One of six main centres for the US FDA has accepted a Drug Master File (DMF) submission for the Albumedix’s Recombumin Elite
Media

Broad stripes, bright stars and a thriving pharmaceutical industry: part II

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” But, given the geography, politics, population, regulation and funding that are unique to the United States, Dr Kevin Robinson looked west to the Land of the Free to find out how the pharmaceutical industry is faring amongst all the milk and honey
Subscribe now